The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Determine if men with erectile dysfunction (ED) are more likely to have insulin resistance compared to healthy controls.
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Cross-Sectional Time Perspective: Prospective |
| Official Title: | The Incidence and Treatment of Insulin Resistance Among Men With Erectile |
| Estimated Enrollment: | 30 |
| Study Start Date: | July 2005 |
| Estimated Study Completion Date: | June 2006 |
Insulin is a hormone produced by the body that lets sugar into the cells, where it is used for energy. Insulin resistance occurs when the body’s cells have a decreased ability to react to insulin. This leads to an increase in insulin secretion. Over time, insulin resistance can lead to higher levels of sugar in the blood (diabetes), and can also contribute to obesity, high blood pressure, high cholesterol levels and heart disease. There are no simple tests to actually diagnose insulin resistance. Currently, the glucose tolerance test is used to diagnose IR, but it involves several blood draws over a 2-hour period. Another purpose of this study is to compare a blood test involving only one blood draw to the 2-hour glucose tolerance test, which involves several blood draws over a 2-hour period.
It is well known that diabetes often leads to erectile dysfunction. Because insulin resistance occurs before diabetes, it is possible that erectile dysfunction may occur in some individuals while they have insulin resistance, but before they develop diabetes. If this is true, it might be possible to use erectile dysfunction as a sign of insulin resistance, which may lead to more timely treatment of insulin resistance and may delay or prevent the development of diabetes, and the other problems mentioned above.
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 18-65 years of age, male,
Exclusion Criteria:
- diabetes, peyronies
Contacts and Locations| Contact: Sue Worley, RN | 717-531-5718 | sworley@psu.edu |
| United States, Pennsylvania | |
| Hershey Med Center | Recruiting |
| Hershey, Pennsylvania, United States, 17033 | |
| Contact: Sue Worley, RN 717-531-5718 sworley@psu.edu | |
| Contact: Danielle Schreiner 717-531-8848 ext 3 dschreiner@psu.edu | |
| Sub-Investigator: Richard Legro, MD | |
| Sub-Investigator: Lawrence Sinoway, MD | |
| Principal Investigator: | J C Trussell, MD |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00284960 History of Changes |
| Other Study ID Numbers: | 18805, NIH: K24 H001476 |
| Study First Received: | January 31, 2006 |
| Last Updated: | January 31, 2006 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Penn State University:
|
erectile dysfunction metabolic syndrome insulin resistance etiology |
Additional relevant MeSH terms:
|
Insulin Resistance Erectile Dysfunction Metabolic Syndrome X Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases Sexual Dysfunction, Physiological Genital Diseases, Male |
Sexual Dysfunctions, Psychological Sexual and Gender Disorders Mental Disorders Insulin Hypoglycemic Agents Physiological Effects of Drugs Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 22, 2013